Abiomed Inc (ABMD) - Medical Equipment - Deals and Alliances Profile

Date: August 22, 2018
Pages: 41
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A28804EEB79EN
Leaflet:

Download PDF Leaflet

Abiomed Inc (ABMD) - Medical Equipment - Deals and Alliances Profile
Summary

Abiomed Inc (Abiomed) is a provider of mechanical circulatory support devices. It develops, manufactures and markets novel technologies designed to replace or assist the pumping function in a failing heart. The company’s heart support and recovery product portfolio includes catheters for circulatory support; minimally invasive implantable cardiac assist devices; and percutaneous catheter-based devices including micro heart pumps, expandable catheter pumps and axial flow pumps. Abiomed also offers automated controllers, designed to control and monitor the catheter performance and display real time hemodynamic and catheter position information. It has manufacturing facilities in Danvers, Massachusetts; and Aachen, Germany. The company sells its products through direct sales and distributors in the Americas, Europe, Asia and the Middle East. Abiomed is headquartered in Danvers, Massachusetts, the US.

Abiomed Inc (ABMD) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion/divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.

NOTE: Out of security concerns GlobalData requires using corporate email address.
Abiomed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Abiomed Inc, Medical Equipment Deals By Type, 2012 to YTD 2018
Abiomed Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018
Abiomed Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018
Abiomed Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018
Abiomed Inc, Medical Equipment, Deal Details
Venture Financing
Magenta Medical Raises USD15 Million in Series B Financing
ALung Technologies Raises Funds through Series C Financing
Partnerships
Abiomed Enters Into Licensing Agreement With Opsens For Optical Sensor Technology
Acquisition
Abiomed Acquires ECP from Syscore for USD13 Million
Abiomed Inc - Key Competitors
Abiomed Inc - Key Employees
Abiomed Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Strategy And Business Planning
Mar 30, 2017: Abiomed Marks Grand Opening of Newly-Expanded Headquarters in Danvers, Massachusetts
Financial Announcements
Jul 26, 2018: Abiomed announces Q1 FY 2019 record revenue of $180 million, Up 36% over prior year
May 03, 2018: Abiomed Announces Q4 FY 2018 Revenue of $174 Million, Up 40%, and Total Year Revenue of $594 Million, Up 33%, Over Prior Year
Feb 01, 2018: Abiomed Announces Q3 FY 2018 Record Revenue of $154 Million, Up 34% Over Prior Year
Jan 08, 2018: Abiomed Announces Preliminary Q3 FY 2018 Revenue of $154M, Up 34% Over Prior Year
Oct 26, 2017: Abiomed Announces Q2 FY 2018 Revenue of $132.8 Million, Up 29% and Record U.S. Patient Utilization, Up 33%
Jul 27, 2017: Abiomed Announces Q1 FY 2018 Revenue of $132.5 Million, Up 29% Over Prior Year
May 04, 2017: Abiomed Announces Q4 FY 2017 Revenue of $124.7 Million, Up 33% Over Prior Year and Total Year Revenue of $445.3 Million, Up 35% Over Prior Year
Jan 26, 2017: Abiomed Announces Q3 FY 2017 Revenue of $114.7 Million, Up 34% Over Prior Year
Jan 09, 2017: Abiomed Announces Preliminary Q3 FY 2017 Revenue of $114.7 Million, Up 34% Over Prior Year
Corporate Communications
Mar 30, 2018: Abiomed to Appoint New Chief Financial Officer Todd A. Trapp
Aug 28, 2017: Abiomed Announces Resignation of Chief Financial Officer and Welcomes Back Former Chief Financial Officer as Consultant
Product News
Mar 05, 2018: Abiomed Showcases Impella Technology that Enables Heart Recovery at ACC with 25 Presentations
Oct 19, 2017: Abiomed's Impella Technology that Enables Heart Recovery Showcased at TCT 2017 With More Than 30 Presentations
Jun 09, 2017: Heart Recovery Patients Visit Capitol Hill to Advocate for Lifesaving Cardiovascular Technology
Mar 19, 2017: First-Ever Presentation on Abiomed's Impella Quality Assurance Program at the 2017 American College of Cardiology Scientific Session
Mar 16, 2017: Abiomed's Impella Technology Showcased at 2017 American College of Cardiology Scientific Session With More Than 10 Presentations
Other Significant Developments
Feb 13, 2018: Abiomed Announces Peripartum and Postpartum Cardiomyopathy Approval and Women's Initiative for Heart Recovery
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Abiomed Inc, Medical Equipment, Key Facts, 2018
Abiomed Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018
Abiomed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Abiomed Inc, Medical Equipment Deals By Type, 2012 to YTD 2018
Abiomed Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018
Abiomed Inc, Deals By Market, 2012 to YTD 2018
Abiomed Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018
Magenta Medical Raises USD15 Million in Series B Financing
ALung Technologies Raises Funds through Series C Financing
Abiomed Enters Into Licensing Agreement With Opsens For Optical Sensor Technology
Abiomed Acquires ECP from Syscore for USD13 Million
Abiomed Inc, Key Competitors
Abiomed Inc, Key Employees
Abiomed Inc, Subsidiaries

LIST OF FIGURES

Abiomed Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018
Abiomed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Abiomed Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018
Abiomed Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018
Abiomed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Abiomed Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018
Abiomed Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018
Abiomed Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018
Skip to top


Ask Your Question

Abiomed Inc (ABMD) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: